Eris Lifesciences has informed that a Meeting of the Board of Directors of the Company is scheduled on Wednesday, July 29, 2026, to, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2026. Further, as informed by them vide letter dated June 26, 2026, the trading window has been already closed from July 01, 2026, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015, and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company’.
The above information is a part of company’s filings submitted to BSE.
